Suchergebnisse - "Stilgenbauer, Stephan"

PubPharm (35)

1

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

enthalten in: The New England journal of medicine | 2023

von Eichhorst, B. | Niemann, C. | Kater, A. | +148

CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):503. - PMID 37237098

2

Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients

enthalten in: Leukemia & lymphoma | 2023

von Kutsch, N. | Holmes, E. | Robrecht, S. | +14

3

Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients : Final analysis of the Phase IIIb GREEN study

enthalten in: British journal of haematology | 2021

von Stilgenbauer, S. | Bosch, F. | Ilhan, O. | +15

4

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL) : a randomized phase 3 trial

enthalten in: Leukemia | 2020

von Herling, C. | Cymbalista, F. | Groß-Ophoff-Müller, C. | +24

5

DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy

enthalten in: Scientific data | 2020

von Yosifov, D. | Bloehdorn, J. | Döhner, H. | +3

6

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia : a subgroup analysis of the GREEN study

enthalten in: Leukemia | 2020

von Bosch, F. | Cantin, G. | Cortelezzi, A. | +13

7

Treatment of Older Patients With Mantle Cell Lymphoma (MCL) : Long-Term Follow-Up of the Randomized European MCL Elderly Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Kluin-Nelemans, H. | Hoster, E. | Hermine, O. | +19

8

Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia : a retrospective, multicohort study

enthalten in: The Lancet. Oncology | 2019

von Herling, C. | Coombes, K. | Benner, A. | +14

CommentIn: Lancet Oncol. 2019 Nov;20(11):1478-1479. - PMID 31582352

9

New lessons learned in T-PLL : results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance

enthalten in: Leukemia & lymphoma | 2019

von Pflug, N. | Cramer, P. | Robrecht, S. | +15

10

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study

enthalten in: Haematologica | 2018

von Leblond, V. | Aktan, M. | Ferra Coll, C. | +10